Clinical Trials in Detroit

Showing 7641-7660 of 19,719 trials

LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum for Girls 15-19

NCT03265314

Alternatives For Girls (AFG) is offering LeadHer as a gender-specific teen pregnancy prevention curriculum to girls between the ages of 14-19 years old who live in Wayne County, MI. The curriculum seeks to demonstrate that girls who participate in LeadHer will show increased rates of avoidance of unprotected sex, will show increased use of birth control and reduced rates of pregnancy. LeadHer will run over a 6-session period covering topics designed to prevent teen pregnancy and develop girls into leaders. The sessions will be co-led by youth (Peer Educators).

Teenage Pregnancy

Alternatives For Girls508 participantsStarted Aug 2017

Detroit, Michigan, United States

COMPLETEDPhase 46.7 miles

Exparel for Postoperative Pain Management in Shoulder Surgery

NCT02472314

The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.

Fracture of Shoulder and Upper Arm

Wayne State University70 participantsStarted Jun 2015

Dearborn, Michigan, United States

COMPLETEDPhase 2/320 miles

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

NCT04322708

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study.

Eosinophilic Esophagitis

Allakos Inc.277 participantsStarted Jul 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Gilbert, Arizona, United States +75 more locations

LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum for Girls 15-19

Exparel for Postoperative Pain Management in Shoulder Surgery

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

Find Trials by Condition in Detroit

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Studying Students at Risk for COVID-19

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Synuclein-One Study

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)